Business France is excited to bring you a top-notch panel exploring diversity as a growth strategy at its annual conference for BIO.
At a time when the biotech business needs to find new avenues to ensure innovation meets the patients, it has become critical to break group-think and ‘one-size-fits-all’ strategies.
Much research now show that Diversity and Inclusion is good for shareholders – diverse teams outperform, companies with women board members outperform. Yet, the Life Sciences industry can do better and panelists will look into some of the current challenges and ways to overcome them before diving into the importance of Diversity to patients. Indeed, getting the right mix in the industry will also benefit patients.
Supported by Sanofi, this high-level round table will also include an interactive part to get best practices from the audience.
• Bill Sibold – CEO, Sanofi Genzyme
• Yvonne Greenstreet - COO, Alnylam
• Edie Stringfellow - Director of Diversity & Inclusion at MassBIO
• Stefan Willsemen - CEO Biomérieux Inc.
Moderated by Vanina Laurent-Ledru – VP Global Public Affairs Sanofi
Mandatory Registration & Photo ID : https://www.eventbrite.com/e/bio-2019-diversity-a-business-imperative-for-the-life-sciences-industry--tickets-61324836236
Session ID: 565537